Whitehawk Therapeutics, Inc. financial data

Symbol
WHWK on Nasdaq
Location
Morristown, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1,330 % +1.8%
Quick Ratio 11.08 % -61%
Debt-to-equity 8.07 % -68.3%
Return On Equity -10.35 % +85.6%
Return On Assets -9.58 % +83.3%
Operating Margin -754 % -1.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47,128,362 shares +91.2%
Common Stock, Shares, Outstanding 47,128,362 shares +91.5%
Common Stock, Value, Issued 4,000 USD +100%
Weighted Average Number of Shares Outstanding, Basic 69,204,899 shares +1.6%
Weighted Average Number of Shares Outstanding, Diluted 69,204,899 shares +1.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14,384,000 USD -42.6%
Research and Development Expense 86,289,000 USD +74.5%
Costs and Expenses 122,846,000 USD +34.6%
Operating Income (Loss) -108,462,000 USD -63.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -15,618,000 USD +74.7%
Earnings Per Share, Basic 0 USD/shares +43.5%
Earnings Per Share, Diluted 0 USD/shares +43.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37,931,000 USD +24.2%
Cash, Cash Equivalents, and Short-term Investments 162,600,000 USD +1.6%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 0 USD -100%
Assets, Current 165,036,000 USD +1.1%
Property, Plant and Equipment, Net 4,000 USD -99.9%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 1,977,000 USD +30.5%
Assets 167,017,000 USD +94.9%
Accounts Payable, Current 1,633,000 USD +18.8%
Accrued Liabilities, Current 8,216 USD
Liabilities, Current 9,849,000 USD -37.7%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 9,849,000 USD -41.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 139,000 USD +2.6%
Retained Earnings (Accumulated Deficit) -329,999,000 USD -5%
Stockholders' Equity Attributable to Parent 157,168,000 USD +1.3%
Liabilities and Equity 167,017,000 USD +94.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11,864,000 USD +39.6%
Net Cash Provided by (Used in) Investing Activities 115,498,000 USD +9.9%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 47,128,362 shares +91.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 198,835,000 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 121,898,000 USD +69%
Operating Lease, Liability 0 USD -100%
Depreciation 131,600 USD -40.5%
Payments to Acquire Property, Plant, and Equipment 551,000 USD -25.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15,518,000 USD +74.8%
Lessee, Operating Lease, Liability, to be Paid 940,000 USD -35.3%
Property, Plant and Equipment, Gross 377,000 USD -94.1%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 231,000 USD -27.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 320,000 USD -37.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 107,000 USD -42.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 280,000 USD +21.2%
Deferred Tax Assets, Operating Loss Carryforwards 49,184,000 USD +12.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits 5,371,000 USD +16.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 109,000 USD -61.1%
Operating Lease, Payments 99,000 USD -21.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 390,000 USD -30.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%